We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
Illumina Announces Scale-Up of Genome Analyzers at the Broad Institute
News

Illumina Announces Scale-Up of Genome Analyzers at the Broad Institute

Illumina Announces Scale-Up of Genome Analyzers at the Broad Institute
News

Illumina Announces Scale-Up of Genome Analyzers at the Broad Institute

Read time:
 

Want a FREE PDF version of This News Story?

Complete the form below and we will email you a PDF version of "Illumina Announces Scale-Up of Genome Analyzers at the Broad Institute"

First Name*
Last Name*
Email Address*
Country*
Company Type*
Job Function*
Would you like to receive further email communication from Technology Networks?

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

Illumina, Inc. has announced that the Broad Institute has purchased 30 additional Genome Analyzers, increasing its total installed base of Illumina systems to 89.

“We’ve significantly expanded our fleet of Genome Analyzers to ramp up our sequencing capabilities in whole genome, whole exome, and whole transcriptome analysis,” said Robert Nicol, director of Sequencing Operations at the Broad Institute. “We are happy with the technology’s accuracy, ease of use and scalability, as well as continued system improvements that have recently enabled us to generate multiple runs with more than 50 gigabases of high quality sequence data.”

“This latest purchase by the Broad Institute is another strong vote of confidence in Illumina’s Genome Analyzer technology and its capacity to evolve to meet the future needs of one of the world’s leading genome centers,” said Matt Posard, vice president of Worldwide Sales at Illumina. “We continue to focus our innovation on simplifying workflow, enhancing scalability and increasing high-quality runs, as the scope of genetic research expands dramatically.”

Designed for facilities of all sizes, the Illumina Genome Analyzer has been adopted across genome centers worldwide, plus individual research labs, core and service facilities, and biotechnology and pharmaceutical companies. The Genome Analyzer offers the highest rate of daily output and user-friendly workflow.

The Genome Analyzer also offers the broadest set of supported applications, including whole transcriptome profiling and discovery, epigenetic studies, whole genome resequencing, de novo sequencing, targeted resequencing, ChIP-sequencing, bi-sulfite sequencing (DNA methylation), small RNA, mRNA, tag profiling and metagenomics.
Advertisement